CalciMedica (CALC) announced a plenary presentation at the 30th International Acute Kidney Injury and Continuous Renal Replacement Therapy ...
CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition ...
Once-thriving landmarks like the ancient city of Palmyra and the medieval Crusader castle of Crac des Chevaliers remain scarred by years of conflict, but local tourists are returning to the sites ...
CalciMedica, headquartered in La Jolla, California, is a leading CRAC-channel company dedicated to reversing the pathology of Ca 2+ dysregulation by the modulation of active and overactive CRAC ...
CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition ...
2 - Update of the List of World Heritage in Danger (Retained Properties) 2023 45COM 8B.67 - Minor boundary modifications - Crac des Chevaliers and Qal’at Salah El-Din, Syrian Arab Republic 2021 44COM ...
The Careers Research and Advisory Centre (CRAC) Pension Scheme has completed a £2.8m full scheme buy-in with Just Group. The transaction secures the benefits of all 30 deferred members of the scheme ...
CalciMedica, headquartered in La Jolla, California, is a leading CRAC-channel company dedicated to reversing the pathology of Ca 2+ dysregulation by the modulation of active and overactive CRAC ...